Autor: |
Guisado-Vasco, P., Carral��n-Gonz��lez, M. M., Aguareles-Gorines, J., Mart��-Ballesteros, E. M., S��nchez-Manzano, M. D., Carnevali-Ruiz, D., Garc��a-Coca, M., Barrena-Puertas, R., de Viedma, R. Garc��a, Luque-Pinilla, J. M., Sotres-Fernandez, G., Fern��ndez-Sousa, J. M., Luepke-Estefan, X. E., L��pez-Mart��n, J. A., Jimeno, J. M. |
Rok vydání: |
2022 |
DOI: |
10.6084/m9.figshare.18132837 |
Popis: |
Additional file 1. Text summarizes methods used, analytical procedures, complications, therapies prescribed during hospitalization and further considerations; Table 1S���4S show analytical parameters that include: absence of immunoresponse against SARS-CoV-2; an increase in lymphocytic populations over time and serum biochemical results during the clinical event. A summary of ISARIC mortality score is also shown. Figure 1S Timeline of qPCR Ct over time, patient shows a reduction in the viral load after the treatment with the second cycle of plitidepsin. Figure 2S Bilateral pneumonia improvement after plitidepsin treatment determined by thorax imagen. |
Databáze: |
OpenAIRE |
Externí odkaz: |
|